• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018
  • Share to Weibo added to Biovista Vizit October 25, 2017

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

PEMBROLIZUMAB

Immune checkpoint blockade in cancer immunotherapy

August 28, 2018Cancer, Cancer Immunotherapy, Vizit Graphs
Immune checkpoint blockade in cancer immunotherapy

Explore immune checkpoint blockade (PD-1, CTLA-4) in cancer immunotherapy with Biovista Vizit. Explore the live graph.

Vizit Graphs Tag Cloud

1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE REMICADE INFLAMMATION CTLA4 IMMUNE RESPONSE RECEPTOR CD4 ANGIOGENESIS DOXORUBICIN IL6 PARKINSON DISEASE TP53 FOXP3 HELICOBACTER PYLORI ALZHEIMER'S DISEASE BREAST CANCER CANCER CELL DEATH AGING METFORMIN CELL DIVISION CLOSTRIDIUM DIFFICILE DIABETES MELLITUS RHEUMATOID ARTHRITIS IL17A TH17 CELLS STREPTOCOCCUS PNEUMONIAE CELL DIFFERENTIATION TNF IL23A CELL PROLIFERATION APOPTOTIC PROCESS STAPHYLOCOCCUS AUREUS INSULIN PSEUDOMONAS AERUGINOSA CANDIDA ALBICANS IFNG PORPHYROMONAS GINGIVALIS ESCHERICHIA COLI LISTERIA MONOCYTOGENES CASP3 NEURODEGENERATIVE DISORDERS SOD1 AUTOPHAGY ERBB-2

© 2019 Biovista Vizit All Rights Reserved.